Home – Capabilities – Biologics – Discovery to Lead – Discovery
DiscoveryDesignDevelopability

Biologic Discovery

Ensuring you take the best antibody candidates forward

Abzena’s antibody discovery team specializes in building the foundations of your program, utilizing state-of-the-art methodologies and equipment, and setting you off on the right track to success.

We tailor our service to your needs to deliver expert assessments of target molecules, immunization strategies and antibody screening cascades.

We apply innovative approaches and equipment to generate robust data that ensures discovery and supports the selection of the best antibody candidates for your development program.

Our Hybridoma MAX™ custom mouse monoclonal antibody discovery service maximizes the number of antibodies discovered through a dual, high-throughput screening platform that creates more candidates for development.

Our methods ensure high affinity antibodies and where required cross-reactivity with the target, and include:

  • Flow cytometry to determine binding conditions
  • SPR analysis (Biacore) to determine affinity
  • In vitro assays to demonstrate functional activity
  • Epitope binning to characterize and select optimally designed mAbs

Hybridoma Sequencing

Our experts have generated 100s of hybridoma cell lines for our partners with our 100%-accurate sequencing platform, giving you the confidence that you are taking the correct sequence forward.

Let’s move medicine forward.

The asset you’re developing right now can make a real difference for human health. Let us use our wealth of experience to deploy the best technologies, shorten lead times and implement effective risk mitigation strategies.

Connect with us.